William Blair & Company
PTLA

William Blair & Company’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

William Blair & Company’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-116,433
Closed -$830K – 1781
2020
Q1 		$830K Sell
116,433
-48,016
-29% -$599K 0.01% 722
2019
Q4 		$3.93M Buy
164,449
+11,795
+8% +$325K 0.02% 445
2019
Q3 		$4.09M Buy
152,654
+5,105
+3% +$143K 0.02% 414
2019
Q2 		$4M Buy
147,549
+9,266
+7% +$291K 0.02% 422
2019
Q1 		$4.8M Buy
138,283
+29,985
+28% +$865K 0.03% 378
2018
Q4 		$2.11M Buy
108,298
+20,107
+23% +$413K 0.02% 514
2018
Q3 		$2.35M Buy
88,191
+3,484
+4% +$114K 0.01% 525
2018
Q2 		$3.2M Buy
84,707
+14,835
+21% +$567K 0.02% 460
2018
Q1 		$2.28M Buy
69,872
+17,409
+33% +$764K 0.02% 525
2017
Q4 		$2.55M Buy
52,463
+7,869
+18% +$398K 0.02% 512
2017
Q3 		$2.41M Buy
44,594
+12,994
+41% +$763K 0.02% 513
2017
Q2 		$1.77M Sell
31,600
-7,126
-18% -$285K 0.01% 596
2017
Q1 		$1.34M Buy
38,726
+18,105
+88% +$577K 0.01% 631
2016
Q4 		$463K Sell
20,621
-3,000
-13% -$58.6K ﹤0.01% 858
2016
Q3 		$536K Buy
23,621
+9,421
+66% +$221K ﹤0.01% 809
2016
Q2 		$335K Buy
+14,200
New +$351K ﹤0.01% 941

Other funds holding PTLA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

William Blair & Company's PTLA Position: Q2 2020 in Review

William Blair & Company sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2020, closing a stake of 116,433 shares — an estimated $830K sold.

William Blair & Company first reported a position in PTLA in Q2 2016 and held it in 16 quarters. The position peaked at $4.8M in Q1 2019. 162 funds tracked by Wall St. Rank hold PTLA as of Q2 2020.

  • William Blair & Company reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • William Blair & Company sold 116,433 Portola Pharmaceuticals, Inc. shares in Q2 2020, an estimated $830K.
  • William Blair & Company first reported a position in Portola Pharmaceuticals, Inc. in Q2 2016 and held it in 16 quarters.
  • William Blair & Company's Portola Pharmaceuticals, Inc. position peaked at $4.8M in Q1 2019.
  • 162 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2020.

Based on William Blair & Company's 13F filing for Q2 2020, filed 12 Aug 2020.